(IBBQ) Invesco Nasdaq Biotechnology - Ratings and Ratios
Exchange: NASDAQ • Country: USA • Currency: USD • Type: Etf • ISIN: US46138G5999 • Health
IBBQ: Biotechnology, Pharmaceuticals, Securities, Stocks, Medicines, Drugs
The fund generally will invest at least 90% of its total assets in the securities that comprise the index. Strictly in accordance with its guidelines and mandated procedures, Nasdaq compiles the underlying index, which is a modified market capitalization weighted index that is designed to measure the performance of securities listed on the Nasdaq Stock Market that are classified as either biotechnology or pharmaceutical companies. The index may include securities of large-, mid- and small-capitalization companies. The fund is non-diversified.
Additional Sources for IBBQ ETF
News:
Wall Street Journal
Benzinga
Yahoo Finance
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
IBBQ ETF Overview
| Market Cap in USD | 38m |
| Category | Health |
| TER | 0.19% |
| IPO / Inception | 2021-06-11 |
IBBQ ETF Ratings
| Growth 5y | -4.01% |
| Fundamental | - |
| Dividend | 56.0% |
| Rel. Strength Industry | -95.1 |
| Analysts | - |
| Fair Price Momentum | 20.23 USD |
| Fair Price DCF | - |
IBBQ Dividends
| Dividend Yield 12m | 1.11% |
| Yield on Cost 5y | 0.99% |
| Annual Growth 5y | 13.55% |
| Payout Consistency | 100.0% |
IBBQ Growth Ratios
| Growth Correlation 3m | -83.8% |
| Growth Correlation 12m | 40.6% |
| Growth Correlation 5y | 6.4% |
| CAGR 5y | -3.05% |
| CAGR/Mean DD 5y | -0.16 |
| Sharpe Ratio 12m | -0.11 |
| Alpha | -22.11 |
| Beta | 0.83 |
| Volatility | 22.13% |
| Current Volume | 11.1k |
| Average Volume 20d | 7.3k |
What is the price of IBBQ stocks?
As of January 23, 2025, the stock is trading at USD 22.12 with a total of 11,079 shares traded.
Over the past week, the price has changed by +2.50%, over one month by +1.79%, over three months by -6.71% and over the past year by +1.31%.
As of January 23, 2025, the stock is trading at USD 22.12 with a total of 11,079 shares traded.
Over the past week, the price has changed by +2.50%, over one month by +1.79%, over three months by -6.71% and over the past year by +1.31%.
Is Invesco Nasdaq Biotechnology a good stock to buy?
Neither. Based on ValueRay Analyses, Invesco Nasdaq Biotechnology is currently (January 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of -4.01 and therefor a technical neutral rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of IBBQ as of January 2025 is 20.23. This means that IBBQ is currently overvalued and has a potential downside of -8.54%.
Neither. Based on ValueRay Analyses, Invesco Nasdaq Biotechnology is currently (January 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of -4.01 and therefor a technical neutral rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of IBBQ as of January 2025 is 20.23. This means that IBBQ is currently overvalued and has a potential downside of -8.54%.
Is IBBQ a buy, sell or hold?
Invesco Nasdaq Biotechnology has no consensus analysts rating.
Invesco Nasdaq Biotechnology has no consensus analysts rating.
What are the forecast for IBBQ stock price target?
According to ValueRays Forecast Model, IBBQ Invesco Nasdaq Biotechnology will be worth about 22.4 in January 2026. The stock is currently trading at 22.12. This means that the stock has a potential upside of +1.08%.
According to ValueRays Forecast Model, IBBQ Invesco Nasdaq Biotechnology will be worth about 22.4 in January 2026. The stock is currently trading at 22.12. This means that the stock has a potential upside of +1.08%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 22.4 | 1.1% |